Loading company…
Until Labs develops cryopreservation technology to extend the viability of donated human organs.
Until Labs develops cryopreservation methods intended to extend the viability of donated human organs from hours to weeks or months. Based in San Francisco, US, the company raised USD 58 mn in Series A funding on September 22, 2025, with Founders Fund, Lux Capital, and Field Ventures participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in